Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Mifamurtide 4 mg powder for suspension for infusion

Active Ingredient:
mifamurtide
Company:  
Takeda UK Ltd See contact details
ATC code: 
L03AX15
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 12 Aug 2024
Takeda UK Ltd
Company image
Address
1 Kingdom Street, London, W2 6BD, UK
Telephone
+44 (0)3333 000 181
Medical Information e-mail
[email protected]
Drug Safety e-mail
[email protected]
Medical Information Direct Line
+44 (0)3333 000 181